Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc.verified

MIST

Price:

$1.27

Market Cap:

$109.08M

Milestone Pharmaceuticals Inc. is a biopharmaceutical company based in Montréal, Canada, specializing in the creation and commercialization of cardiovascular therapeutics. Their flagship product, etripamil, an innovative channel blocker, is currently in advanced clinical development. It is undergoing Phase III trials for the treatment of paroxysmal supraventricular tachycardia (PSVT) in the United States and Canada, while also progressing through Phase II trials for atrial fibrillation and rapid ventricular rate. Furthermore, Milestone Pharmaceuticals has forged a licensing and collaboration alliance with Ji Xing Pharmaceuticals to advance and distribute etripamil for both preventative and t...[Read more]

Industry

Biotechnology

IPO Date

2019-05-09

Stock Exchange

NASDAQ

Ticker

MIST

The Enterprise Value as of June 2026 (TTM) for Milestone Pharmaceuticals Inc. (MIST) is 175.09M

According to Milestone Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 175.09M. This represents a change of 5.83% compared to the average of 165.45M of the last 4 quarters.

Milestone Pharmaceuticals Inc. (MIST) Historical Enterprise Value (quarterly & annually)

How has MIST Enterprise Value performed in the past?

The mean historical Enterprise Value of Milestone Pharmaceuticals Inc. over the last ten years is 183.68M. The current 175.09M Enterprise Value has changed 9.43% with respect to the historical average. Over the past ten years (40 quarters), MIST's Enterprise Value was at its highest in in the June 2019 quarter at 507.76M. The Enterprise Value was at its lowest in in the March 2020 quarter at -56292250.32.

Quarterly (TTM)
Annual

Average

183.68M

Median

160.57M

Minimum

109.75M

Maximum

352.58M

Milestone Pharmaceuticals Inc. (MIST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Milestone Pharmaceuticals Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 60.64%

Maximum Annual Enterprise Value = 352.58M

Minimum Annual Increase = -51.93%

Minimum Annual Enterprise Value = 109.75M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025154.77M-12.21%
2024176.30M60.64%
2023109.75M-32.65%
2022162.96M1.49%
2021160.57M28.21%
2020125.24M-6.12%
2019133.41M-51.93%
2018277.52M-21.29%

Milestone Pharmaceuticals Inc. (MIST) Average Enterprise Value

How has MIST Enterprise Value performed in the past?

The current Enterprise Value of Milestone Pharmaceuticals Inc. (MIST) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

146.94M

5-year avg

152.87M

10-year avg

183.68M

Milestone Pharmaceuticals Inc. (MIST) Enterprise Value vs. Peers

How is MIST’s Enterprise Value compared to its peers?

Milestone Pharmaceuticals Inc.’s Enterprise Value is greater than Rani Therapeutics Holdings, Inc. (43.95M), greater than Molecular Partners AG (38.23M), greater than Applied Therapeutics, Inc. (5.42M), greater than Cardiff Oncology, Inc. (97.39M), less than Elicio Therapeutics, Inc. (282.82M), greater than Cybin Inc. (-90623621.25), greater than Innate Pharma S.A. (141.16M), greater than Corbus Pharmaceuticals Holdings, Inc. (77.82M), greater than Cassava Sciences, Inc. (-26188130.00), greater than PepGen Inc. (76.09M),

Build a custom stock screener for Milestone Pharmaceuticals Inc. (MIST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Milestone Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Milestone Pharmaceuticals Inc. (MIST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Milestone Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Milestone Pharmaceuticals Inc.'s Enterprise Value?

What is the highest Enterprise Value for Milestone Pharmaceuticals Inc. (MIST)?

What is the 3-year average Enterprise Value for Milestone Pharmaceuticals Inc. (MIST)?

What is the 5-year average Enterprise Value for Milestone Pharmaceuticals Inc. (MIST)?

How does the current Enterprise Value for Milestone Pharmaceuticals Inc. (MIST) compare to its historical average?